Curis
CRIS
#10335
Rank
A$26.18 M
Marketcap
A$0.67
Share price
-2.08%
Change (1 day)
-79.15%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.14. In 2024 the company made an earnings per share (EPS) of A-$9.84 an increase over its 2023 EPS that were of A-$12.64.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-41.17%
2024A-$9.84-22.15%
2023A-$12.64-26.17%
2022A-$17.1122.3%
2021A-$13.99-25.37%
2020A-$18.75-30.93%
2019A-$27.15-2.02%
2018A-$27.71
2016A-$62.97-10%
2015A-$69.96138.1%
2014A-$29.3940%
2013A-$20.99-25%
2012A-$27.9966.67%
2011A-$16.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.83-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.98-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.50-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.38-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.44 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$15.73 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.97-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA